CHHMF Stock Chart & Stats
$68.23
--
Market closed
$68.23
--
Day’s Range― - ―
52-Week Range$0.00 - $136.46
Previous CloseN/A
Volume500.00
Average Volume (3M)0.00
Market Cap
$1.51B
Enterprise Value$6.01B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)51.4
Beta0.00
Next Earnings
Feb 03, 2027EPS Estimate
0.98Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.23
Shares Outstanding17,402,480
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap3.99
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$75.02Price Target Upside9.96% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ChemoMetec A/S News
CHHMF FAQ
What was ChemoMetec A/S’s price range in the past 12 months?
ChemoMetec A/S lowest stock price was $0.00 and its highest was $136.46 in the past 12 months.
What is ChemoMetec A/S’s market cap?
ChemoMetec A/S’s market cap is $1.51B.
When is ChemoMetec A/S’s upcoming earnings report date?
ChemoMetec A/S’s upcoming earnings report date is Feb 03, 2027 which is in 103 days.
How were ChemoMetec A/S’s earnings last quarter?
ChemoMetec A/S released its earnings results on Sep 10, 2026. The company reported -$0.228 earnings per share for the quarter, missing the consensus estimate of -$0.173 by -$0.056.
Is ChemoMetec A/S overvalued?
According to Wall Street analysts ChemoMetec A/S’s price is currently Undervalued.
Does ChemoMetec A/S pay dividends?
ChemoMetec A/S does not currently pay dividends.
What is ChemoMetec A/S’s EPS estimate?
ChemoMetec A/S’s EPS estimate is 0.98.
How many shares outstanding does ChemoMetec A/S have?
ChemoMetec A/S has 17,402,480 shares outstanding.
What happened to ChemoMetec A/S’s price movement after its last earnings report?
ChemoMetec A/S reported an EPS of -$0.228 in its last earnings report, missing expectations of -$0.173. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of ChemoMetec A/S?
Currently, no hedge funds are holding shares in CHHMF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ChemoMetec A/S
Headquartered in Allerød, Denmark, and established in 1997, ChemoMetec A/S focuses on the design, production, and worldwide distribution of analytical instruments for cell enumeration and analysis. Their sophisticated solutions are utilized across diverse fields, including cell-based therapeutics, oncology and stem cell research, pharmaceutical development and manufacturing, along with quality assurance for animal semen and beer. The company's product offerings feature a range of NucleoCounter devices, such as the NC-3000 advanced image cytometer, the NC-250 automated cell analyzer, and the consistent NC-202 and NC-200 automated cell counters for viability assessment. Specialized counters include the NucleoCounter SP-100 for automated sperm cell analysis in animal production, the SCC-100 for measuring somatic cells in milk samples, and the YC-100 for total count and viability of yeast cells. Beyond equipment, they also supply vital consumables like cassettes and reagents, various accessories such as software and cables, and offer extensive service and validation plans.
CHHMF Stock 12 Month Forecast
Average Price Target
$75.02
▲(9.96% Upside)
Technical Analysis
Ownership Overview
―
Insiders
8.57% Mutual Funds
― Other Institutional Investors
85.11% Public Companies and
Individual Investors







